A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient: New osteoblastic bone lesions in a lung cancer patient may represent bone flare and should not be misdiagnosed as disease progression

Charlotte De Bondt; Annemiek Snoeckx; Jo Raskin

doi:10.5334/jbsr.1907

A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient: New osteoblastic bone lesions in a lung cancer patient may represent bone flare and should not be misdiagnosed as disease progression

J Belg Soc Radiol. 2020 Apr 27;104(1):18. doi: 10.5334/jbsr.1907.

Authors

Charlotte De Bondt¹, Annemiek Snoeckx¹, Jo Raskin¹

Affiliation

¹ Antwerp University Hospital and University of Antwerp, BE.

Abstract

We report the case of a 72-year-old female never-smoker with stage IV endothelial growth factor receptor (EGFR) mutated lung adenocarcinoma. This patient was started on first line tyrosine kinase inhibitor (TKI) and seemingly developed new bone metastases under this treatment. As there was a remarkable discrepancy between the partial response seen in the primary tumor and non-osseous metastatic locations, the possibility of a bone flare phenomenon was considered. In this case report, we demonstrate that new bony lesions are not always synonymous with disease progression.

Keywords: bone flare; lung cancer; metastases; osteoblastic bone lesions; pseudo lesions.

Publication types

Case Reports